Colgate Buy Hold or Sell Recommendation

<div class='circular--portrait' style='background:#FF6600;color: #FFFAFA;font-size:4em;padding-top: 25px;;'>CP</div>
CL -- USA Stock  

Fiscal Quarter End: 30th of June 2020  

Allowing for the 30-days total investment horizon, and your above average risk tolerance our recommendation regarding Colgate Palmolive is 'Cautious Hold'. Macroaxis provides Colgate Palmolive buy hold or sell recommendation only in the context of selected investment horizon and investor attitude towards risk assumed by holding CL positions. The advice algorithm takes into account all of Colgate Palmolive available fundamental, technical, and predictive indicators you will find on this site. The advice is provided from CL buy-and-hold perspective. Continue to Colgate Palmolive Analyst Recommendation to compare Macroaxis Buy or Sell Recommendation with the current analyst consensus. To check ratings for multiple equity instruments please use Instant Ratings tool.

Search Advice

 
Refresh

Time Horizon

Risk Tolerance

Execute Advice
Sell Colgate PalmoliveBuy Colgate Palmolive
Cautious Hold

Volatility

Hype Condition

Current Valuation

Odds of Distress

Economic Sensitivity

Analyst Consensus

Piotroski F Score

Financial Leverage

For the selected time horizon Colgate Palmolive has a mean deviation of 2.4, semi deviation of 3.14, standard deviation of 3.49, variance of 12.17, downside variance of 10.5 and semi variance of 9.85
Macroaxis provides unbiased buy, hold, or sell recommendation on Colgate Palmolive that should be used to complement current analysts and expert consensus on Colgate Palmolive. Our buy or sell advice engine determines the organization potential to grow exclusively from the perspective of investors current risk tolerance and investing horizon. To make sure Colgate Palmolive is not overpriced, please confirm all Colgate Palmolive fundamentals, including its EBITDA, Book Value Per Share and the relationship between Price to Sales and Cash per Share . Given that Colgate Palmolive has Price to Earning of 24.15 , we suggest you validate Colgate Palmolive market performance and probability of bankruptcy to make sure the company can sustain itself in the current economic cycle given your prevailing risk tolerance and investing horizon.

Colgate Palmolive Trading Alerts and Improvement Suggestions

Colgate Palmolive has very high historical volatility over the last 30 days
The company reports 7.85 B of total liabilities. Colgate Palmolive has Current Ratio of 0.94 implying that it has not enough working capital to pay out debt commitments in time.
Over 81.0% of the company shares are held by institutions such as insurance companies
On 17th of April 2020 Colgate Palmolive paid $ 0.44 per share dividend to its current shareholders

Colgate Palmolive current analysts recommendations

Target Median Price75.00
Target Mean Price73.97
Recommendation Mean2.50
Target High Price91.00
Number Of Analyst Opinions18
Target Low Price52.00
Average Consensus Hold
The consensus estimates and target price estimation is comprised of individual analyst assessments, and may or may not mutch the Macroaxis buy or sell advice. It is determined by taking an average of all analyst recommendations and classifying them as Strong Buy, Buy, Hold, or Sell.

Colgate Palmolive Returns Distribution Density

Mean Return0.023791Value At Risk-4.05
Potential Upside6.56Standard Deviation3.49
 Return Density 
      Distribution 

Institutional Investors

Security TypeSharesValue
Vanguard Group IncCommon Shares80 M5.3 B
Blackrock IncCommon Shares58.8 M3.9 B
State Street CorpCommon Shares42.8 M2.8 B
Massachusetts Financial Services CoCommon Shares35.1 M2.3 B
Wellington Management Group LlpCommon Shares26.6 M1.8 B
Bank Of New York Mellon CorpCommon Shares18.6 M1.2 B
Geode Capital Management LlcCommon Shares14.2 M940 M

Colgate Palmolive Cash Flow Accounts

2014201520162017201820192020 (projected)
Capital Expenditure(757 M)(691 M)(533 M)(553 M)(436 M)(335 M)(361.45 M)
Depreciation Amortization and Accretion442 M449 M443 M475 M511 M519 M528.47 M
Net Cash Flow or Change in Cash and Cash Equivalents127 M(119 M)345 M220 M(809 M)157 M169.39 M
Net Cash Flow Business Acquisitions and Disposals(63 M)217 M(5 M)44 M(727 M)(1.71 B)(1.75 B)
Issuance Purchase of Equity Shares(1.16 B)(1.2 B)(889 M)(892 M)(909 M)(704 M)(759.58 M)
Issuance Repayment of Debt Securities435 M421 M164 M(29 M)(179 M)1.45 B1.56 B
Payment of Dividends and Other Cash Distributions(1.45 B)(1.49 B)(1.51 B)(1.53 B)(1.59 B)(1.61 B)(1.74 B)
Net Cash Flow from Financing(2.17 B)(2.28 B)(2.23 B)(2.45 B)(2.68 B)(870 M)(938.68 M)
Net Cash Flow from Investing(859 M)(685 M)(499 M)(471 M)(1.17 B)(2.1 B)(2.15 B)
Net Cash Flow Investment Acquisitions and Disposals(57 M)(143 M)42 M44 M(13 M)(53 M)(57.18 M)
Net Cash Flow from Operations3.3 B2.95 B3.14 B3.05 B3.06 B3.13 B3.3 B
Effect of Exchange Rate Changes on Cash(142 M)(107 M)(64 M)87 M(16 M)(7 M)(7.55 M)
Share Based Compensation131 M125 M123 M127 M109 M100 M103.27 M

Colgate Palmolive Greeks

α
Alpha over DOW
=-0.03
β
Beta against DOW=0.66
σ
Overall volatility
=3.38
Ir
Information ratio =-0.02

Colgate Palmolive Volatility Alert

Colgate Palmolive shows above average downside volatility of 3.24 for selected time horizon. We advise investors to further inspect Colgate Palmolive to make sure all market timing and asset allocation strategies are consistent with estimation about Colgate Palmolive future alpha.
    
 Better Than Average     
    
 Worse Than Average Compare Colgate Palmolive to competition

Colgate Palmolive Fundamental Vs Peers

FundamentalsColgate PalmolivePeer Average
Return On Asset16.39 (0.14) 
Profit Margin15.86 (1.27) 
Operating Margin26.12 (5.51) 
Current Valuation67.01 B16.62 B
Shares Outstanding856.53 M571.82 M
Shares Owned by Insiders0.24 10.09 
Shares Owned by Institutions80.93 39.21 
Number of Shares Shorted10.75 M4.71 M
Price to Earning24.15 28.72 
Price to Book233.10 9.51 
Price to Sales3.81 11.42 
Revenue15.91 B9.43 B
Gross Profit9.34 B27.38 B
EBITDA4.15 B3.9 B
Net Income2.52 B570.98 M
Cash and Equivalents897 M2.7 B
Cash per Share1.05 5.01 
Total Debt7.85 B5.32 B
Current Ratio0.96 2.16 
Book Value Per Share(0.13) 1.93 K
Cash Flow from Operations3.3 B971.22 M
Short Ratio2.51 4.00 
Earnings Per Share2.93 3.12 
Price to Earnings To Growth4.56 4.89 
Number of Employees34.3 K18.84 K
Beta0.59-0.15
Market Capitalization60.6 B19.03 B
Total Asset7.09 B29.47 B
Retained Earnings22.38 B9.33 B
Working Capital79.4 M1.48 B
Current Asset2.23 B9.34 B
Current Liabilities2.15 B7.9 B
Z Score10.48.72
   Sale by Conway Jill K of 1900 shares of Colgate Palmolive [view details]

Colgate Palmolive Market Momentum

About Colgate Palmolive Buy or Sell Advice

When is the right time to buy or sell Colgate Palmolive? Buying stocks such as Colgate Palmolive isn't very hard. However, what challenging for most investors is doing it at the right time to beat the stock market. Proper market timing is something most people cannot do without sophisticated tools, which help to isolate the right opportunities. Macroaxis provides hands-on modules to deliver winning trades and diversify your portfolios on a daily bases. Although Colgate Palmolive investors may find it confusing at the beginning, most of our advising modules are very easy to use and apply. Please read more on our stock advisor page.

Did You Try This Idea?

Run Health Management Thematic Idea Now

Health Management
Health Management Theme
Major hospitals and healthcare providers. Health Management theme has 30 constituents.
View All  Next Launch Health Management
Continue to Colgate Palmolive Analyst Recommendation to compare Macroaxis Buy or Sell Recommendation with the current analyst consensus. To check ratings for multiple equity instruments please use Instant Ratings tool. Please also try Competition Analyzer module to analyze and compare many basic indicators for a group of related or unrelated entities.
Macroaxis is not a registered investment advisor or broker/dealer. All investments, including stocks, funds, ETFs, or cryptocurrencies, are speculative and involve substantial risk of loss. We encourage our investors to invest carefully. Much of our information is derived directly from data published by companies or submitted to governmental agencies which we believe are reliable, but are without our independent verification. Therefore, we cannot assure you that the information is accurate or complete. We do not in any way warrant or guarantee the success of any action you take in reliance on our statements or recommendations. Also, note that past performance is not necessarily indicative of future results. All investments carry risk, and all investment decisions of an individual remain the responsibility of that individual. There is no guarantee that systems, indicators, or signals will result in profits or that they will not result in losses. All investors are advised to fully understand all risks associated with any investing they choose to do. Hypothetical or simulated performance is not indicative of future results. We make no representations or warranties that any investor will, or is likely to, achieve profits similar to those shown because hypothetical or simulated performance is not necessarily indicative of future results. For more information please visit our terms and condition page